At The Network, we are dedicated to ensuring the sustainability of independent, community-based oncology care. As a leader in community oncology support, we understand the importance of enabling independent practices to thrive and deliver high-quality, patient-centered cancer care. Our focus remains on advocating for the interests of independent oncology practices and taking a stand against anticompetitive behavior that threatens the healthcare industry. The Network believes that a competitive healthcare market promotes higher quality, lower cost care, and supports innovation. We stand against anticompetitive behavior that undermines physician autonomy, reduces access to care, and limits patient choice. Together, we aim to ensure independent practices thrive and patients receive exceptional community care. #PublicPolicy #AdvocacyEfforts #IndependentOncologyCare #PatientCentered
The US Oncology Network’s Post
More Relevant Posts
-
July is Sarcoma & Bone Cancer Awareness Month. This rare cancer type accounts for approximately 1% of adult cancers and 15-20% of childhood cancers. Unfortunately, sarcoma is often resistant to existing treatment methods, and there is a need for new therapeutic options. Clinical trials and research play a vital role in improving treatment options and overall survival for these cancers. #ClinicalTrials #SarcomaAwarenessMonth #BoneCancerAwareness #CancerResearch
-
-
Practices in The Network are committed to providing patients with the highest quality care possible. One of the ways they do this is by investing in cutting-edge technology, which enables better care and improved efficiency. For example, Shenandoah Oncology has made significant investments in its lab and now has a brand new Ortho XT3400, allowing the practice to better serve its patients. #CommunityOncology #Technology #PatientCare
Exciting news alert! 🎉🔬 Shenandoah Oncology Lab is stepping up our game to better serve you! 💪✨ We are thrilled to announce that we are making significant investments in our lab to enhance our capabilities and deliver even faster results. ⚡️🔍 Introducing our brand-new Ortho XT3400, this instrument has cutting-edge technology that will revolutionize our testing process. 🌟 This state-of-the-art laboratory analyzer will allow us to bring more testing in-house, meaning quicker turnaround times and improved efficiency. 💯🚀 At Shenandoah Oncology, our top priority is providing you with the highest quality service and care. By investing in this advanced technology, we aim to streamline our operations and deliver your results sooner, ensuring a smoother and more efficient experience for all. 🙌💙 Stay tuned for more updates as we continue to innovate and improve our services. We are so grateful for your trust and support, and we can't wait to bring you the best possible lab experience! 🌈🔬 #ShenandoahOncologyLab #Innovation #CuttingEdge #BetterTogether #FasterResults #QualityCare
-
-
Thank you to Misty Chicchirichi, Sr. Quality Programs Manager at Shenandoah Oncology, and Evan Osborne, MBA, MPH, BSRT(T) (ARRT), PMP, Value-Based Care Program Manager at The Network, for representing The Network at the 2024 CMS Health Equity Conference! Misty had the honor of presenting as part of a distinguished panel, shedding light on the groundbreaking work being done by Shenandoah Oncology to promote health equity. Her presentation was nothing short of inspiring, as she discussed various initiatives including HRSN screening, Findhelp utilization, lay navigation, and Health Equity Planning. As we continue to navigate the complex challenges of health equity, it is crucial to celebrate the progress being made. Together, we can create a future where health equity is a reality for every individual. #HealthEquity #CMSHealthEquityConference #SocialDeterminantsOfHealth
-
-
Dr. Andre Goy, Chief Science Officer for Regional Cancer Care Associates, was recently named to the NJBIZ 2024 Health Care Power 50! Congratulations to Dr. Goy and to RCCA!
Congratulations to Dr. Andre Goy, RCCA's Chief Science Officer, for being named to the NJBIZ 2024 Health Care Power 50!
-
Nine of Texas Oncology's San Antonio physicians were recently selected as 2024 Outstanding Women in Medicine by Scene in SA Magazine. Congratulations to these incredible physicians and the practice on this achievement! #TopDoctors #WomenInMedicine
Congratulations to some of our amazing San Antonio physicians who were selected as the 2024 Outstanding Women in Medicine by the Scene In Sa Magazine! ⭐ Melissa Crawley, M.D. ⭐ Allyson Harroff. M.D. ⭐ Corinne Jeppson, D.O., FACOOG ⭐ Jennifer Lee, M.D. ⭐ Janice Mullins, D.O ⭐ Shruti Sharma, D.O., FACP ⭐ Sharon Wilks, M.D., FACP ⭐ Alison Barron, M.D., FACS ⭐ Rachel E. Kaczynski, D.O., FACOS, FSSO
-
-
-
-
-
+2
-
-
"Shining brightly as a beacon of innovation and enhanced healthcare, OHC is transforming the treatment process for patients with cancer and blood disorders," reads this article in North America Outlook Magazine. Congratulations to the team at OHC - Oncology Hematology Care for this recent feature piece that showcases the practice's clinical excellence, unmatched personal support, and outstanding care for patients with cancer and complex blood disorders. #CancerCare #CommunityOncology
Out Now! Issue 23 of North America Outlook Magazine, the B2B magazine for the North American region features 18+ CEOs, CxOs, Presidents, VPs, and many more providing B2B industry insights, Case Studies, Executive Interviews, Company Profiles and more... Read Issue 23 here ⬇️ https://lnkd.in/dwhmFFcP Issue 23 features: Chandra Marshall, Vice President and General Manager, Lockheed Martin CESAR CASTIÑEIRA DIAZ, President and CEO, RESONAC - Graphite Business Unit David Drosick, President, OHC - Oncology Hematology Care J. Austin Bell, Senior Director, Drew Company Alexandre Lebeau, Vice President of Sales and Marketing, and Greg Van Bemden, Vice President of Engineering, Aerosonic Sylvain Dube, General Manager of Business Strategies, Waterville TG Leon de Bruyn, President and CEO, Lummus Technology Nicolas Roucou, CEO, Décathlon Canada Dany Rheault, Senior Vice President of Engineering, Daifuku Intralogistics America Dr. Lawrence Rosenberg, President and CEO, CIUSSS du Centre-Ouest-de-l'Île-de-Montréal | CIUSSS West-Central Montreal Luke Martin, COO, A1 Garage Door Service Kevin Wolter, Director of Business Development, Invio Automation Vincent Houle, President, MI Integration Thierry Lachapelle, CEO, Etalex Len De Gans, President and CEO, Rally Engineering John Kwapis, President, Kentucky Trailer Fabio Molinaro, Creative Director and Partner, Robilant Cara DeAnda, COO, Galaxy Builders, Ltd. Tom Rannelli, P. Eng., Director of Canadian Operations, GMS Mine Repair & Maintenance #manufacturing #supplychain #logistics #maritime #oilgas #mining #aerospace #aviation #healthcare #construction #oilgas #retail #northamerica #canada #usa #b2b #digitalmagazine #interviews #ceo #predisent #cxo #vp #president
Inside North America Outlook Magazine (Issue 23)
North America Outlook Magazine on LinkedIn
-
Last month, Virginia Cancer Specialists, P.C., opened its newest facility in Northern Virginia--the practice's third expansion in just 6 months. Congratulations to the practice on this expansion, which will increase Virginians' access to care. #CancerCare #CommunityOncology
Exciting news! We're thrilled to share that our expanded cancer office in Northern Virginia has been featured in the Washington Business Journal. Read all about the multimillion-dollar expansion and how we're enhancing care for our community. Read more here: #VirginiaCancerSpecialists #CancerCare #NorthernVirginia #Healthcare #Expansion #CommunityHealth #Oncology #MedicalNews Washington Business Journal The US Oncology Network Elise Sullivan https://bizj.us/1ql878
Northern Virginia cancer practice executing multimillion-dollar expansion - Washington Business Journal
bizjournals.com
-
In research presented at the 2024 American Society of Clinical Oncology Annual Meeting, our team found that while more hospitalizations were observed in older adults enrolled in cancer clinical trials, clinical trial participation is not associated with suboptimal end of life care. Read more about our findings in this article from McKnight's Long-Term Care News. https://lnkd.in/gRANinF6 #ASCO24 #ClinicalTrials
Older adults in cancer clinical trials don’t have more ER, observational visits, data shows
https://www.mcknights.com
-
Congratulations to the Maryland Oncology Hematology MID team, which recently collaborated with NCODA to publish a PQI outlining best practices for patient selection and management of patients receiving Brukinsa. #PQI #ClinicalResources
The MID team at MOH was excited to collaborate with NCODA to publish a PQI, a clinical resource guide, to outline the best practices for patient selection and management of patients receiving Brukinsa. This resource will serve as a tool for MID teams across the United States. A big thank you to Dr. Narang, Courtney Horn, Brandon Sutherland, and Heather Finneyfrock. Click here to read the full article https://bit.ly/3PQR7IR Learn more at https://lnkd.in/eJFKzjB
-
